Sequencing Reagents Market Report 2026

The sequencing reagents market size has grown rapidly in recent years. It will grow from $12.19 billion in 2025 to $14.2 billion in 2026 at a compound annual growth rate (CAGR) of 16.5%. The growth in the historic period can be attributed to growing genomics research, adoption of next-generation sequencing, government funding for genomics, biotech advancements, increasing academic research projects.

The sequencing reagents market size is expected to see rapid growth in the next few years. It will grow to $24.47 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to integration of AI in sequencing, expansion of personalized medicine, growth of biopharma R&D, development of cost-effective reagents, adoption of high-throughput sequencing platforms. Major trends in the forecast period include high-throughput sequencing reagents, NGS library preparation kits, CRISPR-based reagents, cloud-connected sequencing platforms, multiplexing solutions.

The growing demand and development of personalized medicine are expected to drive the growth of the sequencing reagents market in the coming years. Personalized medicine, also called precision medicine, is an innovative approach that customizes healthcare decisions and interventions based on the unique characteristics of each patient. This rising demand is supported by advances in genomics and molecular diagnostics, which enable treatments tailored to individual genetic profiles and disease characteristics. Sequencing reagents are essential to personalized medicine, as they allow precise analysis of genetic information for customized diagnostic and therapeutic strategies. For example, in April 2024, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that in Q4 2023, the number of phase III gene therapy clinical trials increased by 10%, marking the first quarterly rise since Q3 2022. Therefore, the expanding demand for personalized medicine is fueling the sequencing reagents market.

Key companies in the sequencing reagents market are focusing on innovative technologies, such as Illumina Complete Long Read technology, to maintain a competitive advantage. Illumina Complete Long Read technology is an advanced sequencing method that combines the high accuracy and throughput of short-read sequencing with the comprehensive coverage and ability to resolve complex genomic regions offered by long-read sequencing. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina Complete Long Read Prep, Human. This high-performance, long-read human whole-genome sequencing (WGS) assay is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. The Complete Long Read Prep workflow facilitates long-read sequencing of the human genome on Illumina platforms, covering sample processing, library preparation, and sequencing. It enables researchers to generate long sequencing reads for detailed genomic analyses, including the identification of structural variations and complex genomic regions.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, acquired Verogen for $150 million. This acquisition builds on the two companies’ previous collaboration, which began in 2021, and provides Qiagen with distribution rights for several of Verogen’s products, including its GEDmatch genetic code analysis tool and next-generation sequencing panels. Verogen is a US-based biotechnology company specializing in next-generation sequencing-based human identification products.

Major companies operating in the sequencing reagents market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Group, Beckman Coulter Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies IDT, Twist Bioscience, Diagenode, Covaris Inc., Oxford Nanopore Technologies plc, Takara Bio Inc., New England Biolabs NEB, Pacific Biosciences of California Inc., Zymo Research, Lucigen Corporation, Norgen Biotek Corp., Lexogen GmbH, Daicel Arbor Biosciences, Swift Biosciences Inc.

North America was the largest region in the sequencing reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sequencing reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the sequencing reagents market by increasing the cost of imported enzymes, nucleotides, library preparation kits, and specialty chemicals used in next-generation and third-generation sequencing workflows. Research institutes, pharmaceutical companies, and clinical laboratories in Asia-Pacific and Europe, which rely heavily on cross-border reagent supply, are most affected by rising procurement costs. These increases have slowed adoption of high-throughput sequencing in oncology, reproductive health, and agrigenomics applications. At the same time, tariffs are encouraging domestic reagent manufacturing and regional sourcing, strengthening long-term supply security in the sequencing reagents market.

The sequencing reagents market research report is one of a series of new reports that provides sequencing reagents market statistics, including sequencing reagents industry global market size, regional shares, competitors with a sequencing reagents market share, detailed sequencing reagents market segments, market trends and opportunities, and any further data you may need to thrive in the sequencing reagents industry. This sequencing reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sequencing reagents are chemicals or compounds used in various sequencing techniques to determine the exact order of nucleotides in DNA or RNA molecules. They are employed in genetic sequencing methods to identify nucleotide sequences, facilitating precise analysis of genetic information.

The main types of sequencing reagents include library kits, template kits, control kits, sequencing kits, and others. Library kits consist of reagents used to prepare DNA or RNA samples for sequencing, including steps such as fragmentation, adapter ligation, and amplification, enabling researchers to create sequencing-ready libraries. The technologies involved include Sanger sequencing, next-generation sequencing, and third-generation sequencing. Applications span oncology, reproductive health, clinical research, agrigenomics, forensics, and more, serving industry verticals such as research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The sequencing reagents market consists of sales of enzymes, nucleotides, primers, buffers, fluorescent dyes, and cleanup kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.